DD117250A1 - - Google Patents
Info
- Publication number
- DD117250A1 DD117250A1 DD18247674A DD18247674A DD117250A1 DD 117250 A1 DD117250 A1 DD 117250A1 DD 18247674 A DD18247674 A DD 18247674A DD 18247674 A DD18247674 A DD 18247674A DD 117250 A1 DD117250 A1 DD 117250A1
- Authority
- DD
- German Democratic Republic
Links
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DD18247674A DD117250A1 (en:Method) | 1974-11-20 | 1974-11-20 |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DD18247674A DD117250A1 (en:Method) | 1974-11-20 | 1974-11-20 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DD117250A1 true DD117250A1 (en:Method) | 1976-01-05 |
Family
ID=5498134
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DD18247674A DD117250A1 (en:Method) | 1974-11-20 | 1974-11-20 |
Country Status (1)
| Country | Link |
|---|---|
| DD (1) | DD117250A1 (en:Method) |
Cited By (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5032405A (en) * | 1989-09-27 | 1991-07-16 | Warner-Lambert Company | Oral pharmaceutical composition for acid sensitive proteinaceous agents |
| US6541001B1 (en) | 1999-08-24 | 2003-04-01 | Teva Pharmaceutical Industries, Ltd. | Vaccine composition and method of using the same |
-
1974
- 1974-11-20 DD DD18247674A patent/DD117250A1/xx unknown
Cited By (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5032405A (en) * | 1989-09-27 | 1991-07-16 | Warner-Lambert Company | Oral pharmaceutical composition for acid sensitive proteinaceous agents |
| US6541001B1 (en) | 1999-08-24 | 2003-04-01 | Teva Pharmaceutical Industries, Ltd. | Vaccine composition and method of using the same |